References
Ferlazzo E, Giussani G, Gasparini S, et al (2022) Rapid versus slow withdrawal of antiepileptic monotherapy in two-year seizure-free adults patients with epilepsy (RASLOW) study: a pragmatic multicentre, prospective, randomized, controlled study [published online ahead of print, 2022 Jun 1]. Neurol Sci. https://doi.org/10.1007/s10072-022-06121-9
Gasparini S, Ferlazzo E, Giussani G et al (2016) Rapid versus slow withdrawal of antiepileptic monotherapy in 2-year seizure-free adult patients with epilepsy (RASLOW) study: a pragmatic multicentre, prospective, randomized, controlled study. Neurol Sci 37(4):579–583. https://doi.org/10.1007/s10072-016-2483-3
Vickery BG, Perrine KR, Hays RD, Hermann BP, Cramer JA, Meador KJ, Devinski O (1993) Quality of life in epilepsy QOLIE-31 (version 1.0) scoring manual. Copyright RAND. https://www.rand.org/content/dam/rand/www/external/health/surveys_tools/qolie/qolie31_scoring.pdf
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
None.
Informed consent
Not applicable.
Conflict of interest
None.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Panigrahi, B., Tripathi, M. Rapid versus slow withdrawal of antiepileptic monotherapy in 2‑year seizure‑free adult patients with epilepsy (RASLOW) study: a pragmatic multicenter, prospective, randomized, and controlled study—letter to the editor. Neurol Sci 43, 6991–6992 (2022). https://doi.org/10.1007/s10072-022-06368-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-022-06368-2